SEARCH

SEARCH BY CITATION

References

  • Aguilera G., Kiss A. and Sunar-Akbasak B. (1995) Hyperreninemic hypoaldosteronism after chronic stress in the rat. J. Clin. Invest. 96, 15121519.
  • Bernet F., Dedieu J. F., Laborie C., Montel V. and Dupouy J. P. (1998) Circulating neuropeptide Y (NPY) and catecholamines in rat under resting and stress conditions. Arguments for extra-adrenal origin of NPY, adrenal and extra-adrenal sources of catecholamines. Neurosci. Lett. 250, 4548.
  • Bloom S. R., Edwards A. V. and Jones C. T. (1988) The adrenal contribution to the neuroendocrine responses to splanchnic nerve stimulation in conscious calves. J. Physiol. 397, 513526.
  • Castagne V., Corder R., Gaillard R. and Mormede P. (1987) Stress-induced changes of circulating neuropeptide Y in the rat: comparison with catecholamines. Regul. Pept. 19, 5563.
  • Cavadas C., Silva A. P., Mosimann F., Cotrim M. D., Ribeiro C. A., Brunner H. R. and Grouzmann E. (2001) NPY regulates catecholamine secretion from human adrenal chromaffin cells. J. Clin. Endocrinol. Metab. 86, 59565963.
  • Cavadas C., Cefai D., Rosmaninho-Salgado J. et al. (2006) Deletion of the neuropeptide Y (NPY) Y1 receptor gene reveals a regulatory role of NPY on catecholamine synthesis and secretion. Proc. Natl Acad. Sci. USA 103, 1049710502.
  • Chuang D. M. and Costa E. (1974) Biosynthesis of tyrosine hydroxylase in rat adrenal medulla after exposure to cold. Proc. Natl Acad. Sci. USA 71, 45704574.
  • Doods H. N., Wieland H. A., Engel W., Eberlein W., Willim K. D., Entzeroth M., Wienen W. and Rudolf K. (1996) BIBP 3226, the first selective neuropeptide Y1 receptor antagonist: a review of its pharmacological properties. Regul. Pept. 65, 7177.
  • Doods H., Gaida W., Wieland H. A., Dollinger H., Schnorrenberg G., Esser F., Engel W., Eberlein W. and Rudolf K. (1999) BIIE0246: a selective and high affinity neuropeptide Y Y(2) receptor antagonist. Eur. J. Pharmacol. 384, R3R5.
  • Ebert S. N., Rong Q., Boe S., Thompson R. P., Grinberg A. and Pfeifer K. (2004) Targeted insertion of the Cre-recombinase gene at the phenylethanolamine n-methyltransferase locus: a new model for studying the developmental distribution of adrenergic cells. Dev. Dyn. 231, 849858.
  • Eiden L. E., Giraud P., Dave J. R., Hotchkiss A. J. and Affolter H. U. (1984) Nicotinic receptor stimulation activates enkephalin release and biosynthesis in adrenal chromaffin cells. Nature 312, 661663.
  • Engeland W. C., Levay-Young B. K., Rogers L. M. and Fitzgerald D. (1997) Differential gene expression of cytochrome P450 11beta-hydroxylase in rat adrenal cortex after in vivo activation. Endocrinology 138, 23382346.
  • Evequoz D., Grouzmann E., Nussberger J., Niederberger M., Brunner H. R. and Waeber B. (1995) Beta-adrenoceptor stimulation increases neuropeptide Y release from sympathetic nerves in intact rats. Regul. Pept. 58, 163166.
  • Figueiredo H. F., Bodie B. L., Tauchi M., Dolgas C. M. and Herman J. P. (2003) Stress integration after acute and chronic predator stress: differential activation of central stress circuitry and sensitization of the hypothalamo-pituitary-adrenocortical axis. Endocrinology 144, 52495258.
  • Fluharty S. J., Snyder G. L., Stricker E. M. and Zigmond M. J. (1983) Short- and long-term changes in adrenal tyrosine hydroxylase activity during insulin-induced hypoglycemia and cold stress. Brain Res. 267, 384387.
  • Fu L. Y., Acuna-Goycolea C. and van den Pol A. N. (2004) Neuropeptide Y inhibits hypocretin/orexin neurons by multiple presynaptic and postsynaptic mechanisms: tonic depression of the hypothalamic arousal system. J. Neurosci. 24, 87418751.
  • Guyenet P. G. (2006) The sympathetic control of blood pressure. Nat. Rev. Neurosci. 7, 335346.
  • Hamelink C., Tjurmina O., Damadzic R., Young W. S., Weihe E., Lee H. W. and Eiden L. E. (2002) Pituitary adenylate cyclase-activating polypeptide is a sympathoadrenal neurotransmitter involved in catecholamine regulation and glucohomeostasis. Proc. Natl Acad. Sci. USA 99, 461466.
  • Han S., Chen X., Yang C. L., Vickery L., Wu Y., Naes L., Macarthur H. and Westfall T. C. (2005) Influence of cold stress on neuropeptide Y and sympathetic neurotransmission. Peptides 26, 26032609.
  • Henion P. D. and Landis S. C. (1990) Asynchronous appearance and topographic segregation of neuropeptide-containing cells in the developing rat adrenal medulla. J. Neurosci. 10, 28862896.
  • Hexum T. D., Zheng J. and Zhu J. (1994) Neuropeptide Y inhibition of nicotinic receptor-mediated chromaffin cell secretion. J. Pharmacol. Exp. Ther. 271, 6166.
  • Higuchi H., Costa E. and Yang H. Y. (1988) Neuropeptide Y inhibits the nicotine-mediated release of catecholamines from bovine adrenal chromaffin cells. J. Pharmacol. Exp. Ther. 244, 468474.
  • Hiremagalur B., Kvetnansky R., Nankova B., Fleischer J., Geertman R., Fukuhara K., Viskupic E. and Sabban E. L. (1994) Stress elicits trans-synaptic activation of adrenal neuropeptide Y gene expression. Brain. Res. Mol. Brain. Res. 27, 138144.
  • Jahng J. W., Houpt T. A., Joh T. H. and Wessel T. C. (1997) Expression of catecholamine-synthesizing enzymes, peptidylglycine alpha-amidating monooxygenase, and neuropeptide Y mRNA in the rat adrenal medulla after acute systemic nicotine. J. Mol. Neurosci. 8, 4552.
  • Kanatani A., Ishihara A., Iwaasa H. et al. (2000) L-152,804: orally active and selective neuropeptide Y Y5 receptor antagonist. Biochem. Biophys. Res. Commun. 272, 169173.
  • Kuzmiski J. B., Marty V., Baimoukhametova D. V. and Bains J. S. (2010) Stress-induced priming of glutamate synapses unmasks associative short-term plasticity. Nat. Neurosci. 13, 12571264.
  • Kvetnansky R., Sabban E. L. and Palkovits M. (2009) Catecholaminergic systems in stress: structural and molecular genetic approaches. Physiol. Rev. 89, 535606.
  • Leng G. and Ludwig M. (2008) Neurotransmitters and peptides: whispered secrets and public announcements. J. Physiol. 586, 56255632.
  • Lilly M. P., Engeland W. C. and Gann D. S. (1986) Adrenal medullary responses to repeated hemorrhage in conscious dogs. Am. J. Physiol. 251, R1193R1199.
  • Lundberg J. M., Hokfelt T., Hemsen A., Theodorsson-Norheim E., Pernow J., Hamberger B. and Goldstein M. (1986) Neuropeptide Y-like immunoreactivity in adrenaline cells of adrenal medulla and in tumors and plasma of pheochromocytoma patients. Regul. Pept. 13, 169182.
  • Mahata S. K., Mahapatra N. R., Mahata M., Wang T. C., Kennedy B. P., Ziegler M. G. and O'Connor D. T. (2003) Catecholamine secretory vesicle stimulus-transcription coupling in vivo. Demonstration by a novel transgenic promoter/photoprotein reporter and inhibition of secretion and transcription by the chromogranin A fragment catestatin. J. Biol. Chem. 278, 3205832067.
  • Marsh D. J., Hollopeter G., Kafer K. E. and Palmiter R. D. (1998) Role of the Y5 neuropeptide Y receptor in feeding and obesity. Nat. Med. 4, 718721.
  • McCrimmon R. J. and Sherwin R. S. (2010) Hypoglycemia in type 1 diabetes. Diabetes 59, 23332339.
  • Michel M. C., Beck-Sickinger A., Cox H., Doods H. N., Herzog H., Larhammar D., Quirion R., Schwartz T. and Westfall T. (1998) XVI. International Union of Pharmacology recommendations for the nomenclature of neuropeptide Y, peptide YY, and pancreatic polypeptide receptors. Pharmacol. Rev. 50, 143150.
  • Mitchell G. C., Wang Q., Ramamoorthy P. and Whim M. D. (2008) A common single nucleotide polymorphism alters the synthesis and secretion of neuropeptide Y. J. Neurosci. 28, 1442814434.
  • Morris M., Kapoor V. and Chalmers J. (1987) Plasma neuropeptide Y concentration is increased after hemorrhage in conscious rats: relative contributions of sympathetic nerves and the adrenal medulla. J. Cardiovasc. Pharmacol. 9, 541545.
  • Morrison S. F. and Cao W. H. (2000) Different adrenal sympathetic preganglionic neurons regulate epinephrine and norepinephrine secretion. Am. J. Physiol. Regul. Integr. Comp. Physiol. 279, R1763R1775.
  • Nankova B., Kvetnansky R., McMahon A., Viskupic E., Hiremagalur B., Frankle G., Fukuhara K., Kopin I. J. and Sabban E. L. (1994) Induction of tyrosine hydroxylase gene expression by a nonneuronal nonpituitary-mediated mechanism in immobilization stress. Proc .Natl Acad. Sci. USA 91, 59375941.
  • Naveilhan P., Hassani H., Canals J. M. et al. (1999) Normal feeding behavior, body weight and leptin response require the neuropeptide Y Y2 receptor. Nat. Med. 5, 11881193.
  • Petrovic J., Walsh P. L., Thornley K. T., Miller C. E. and Wightman R. M. (2010) Real-time monitoring of chemical transmission in slices of the murine adrenal gland. Endocrinology 151, 17731783.
  • Qian J., Colmers W. F. and Saggau P. (1997) Inhibition of synaptic transmission by neuropeptide Y in rat hippocampal area CA1: modulation of presynaptic Ca2+ entry. J. Neurosci. 17, 81698177.
  • Raghuraman G., Kalari A., Dhingra R., Prabhakar N. R. and Kumar G. K. (2011) Enhanced neuropeptide Y synthesis during intermittent hypoxia in the rat adrenal medulla: role of reactive oxygen species-dependent alterations in precursor peptide processing. Antioxid. Redox Signal. 14, 11791190.
  • Ramamoorthy P. and Whim M. D. (2008) Trafficking and fusion of neuropeptide Y-containing dense-core granules in astrocytes. J. Neurosci. 28, 1381513827.
  • Ramanathan R. and Cryer P. E. (2011) Adrenergic mediation of hypoglycemia-associated autonomic failure. Diabetes 60, 602606.
  • Rosmaninho-Salgado J., Araujo I. M., Alvaro A. R., Duarte E. P. and Cavadas C. (2007) Intracellular signaling mechanisms mediating catecholamine release upon activation of NPY Y1 receptors in mouse chromaffin cells. J. Neurochem. 103, 896903.
  • Saal D., Dong Y., Bonci A. and Malenka R. C. (2003) Drugs of abuse and stress trigger a common synaptic adaptation in dopamine neurons. Neuron 37, 577582.
  • Sainsbury A., Schwarzer C., Couzens M., Fetissov S., Furtinger S., Jenkins A., Cox H. M., Sperk G., Hokfelt T. and Herzog H. (2002) Important role of hypothalamic Y2 receptors in body weight regulation revealed in conditional knockout mice. Proc. Natl Acad. Sci. USA 99, 89388943.
  • Scheurink A. and Ritter S. (1993) Sympathoadrenal responses to glucoprivation and lipoprivation in rats. Physiol. Behav. 53, 9951000.
  • Schroeder J. P., Overstreet D. H. and Hodge C. W. (2005) The neuropeptide-Y Y5 receptor antagonist L-152,804 decreases alcohol self-administration in inbred alcohol-preferring (iP) rats. Alcohol 36, 179186.
  • Shi Y. C., Lin S., Wong I. P. et al. (2010) NPY neuron-specific Y2 receptors regulate adipose tissue and trabecular bone but not cortical bone homeostasis in mice. PLoS. One. 5, e11361.
  • Stanic D., Brumovsky P., Fetissov S., Shuster S., Herzog H. and Hokfelt T. (2006) Characterization of neuropeptide Y2 receptor protein expression in the mouse brain. I. Distribution in cell bodies and nerve terminals. J. Comp. Neurol. 499, 357390.
  • Sun Q. Q., Akk G., Huguenard J. R. and Prince D. A. (2001) Differential regulation of GABA release and neuronal excitability mediated by neuropeptide Y1 and Y2 receptors in rat thalamic neurons. J. Physiol. 531, 8194.
  • Thoenen H. (1970) Induction of tyrosine hydroxylase in peripheral and central adrenergic neurones by cold-exposure of rats. Nature 228, 861862.
  • Thoenen H., Mueller R. A. and Axelrod J. (1969a) Trans-synaptic induction of adrenal tyrosine hydroxylase. J. Pharmacol. Exp. Ther. 169, 249254.
  • Thoenen H., Mueller R. A. and Axelrod J. (1969b) Increased tyrosine hydroxylase activity after drug-induced alteration of sympathetic transmission. Nature 221, 1264.
  • van den Pol A. N., Yao Y., Fu L. Y., Foo K., Huang H., Coppari R., Lowell B. B. and Broberger C. (2009) Neuromedin B and gastrin-releasing peptide excite arcuate nucleus neuropeptide Y neurons in a novel transgenic mouse expressing strong Renilla green fluorescent protein in NPY neurons. J. Neurosci. 29, 46224639.
  • Varndell I. M., Polak J. M., Allen J. M., Terenghi G. and Bloom S. R. (1984) Neuropeptide tyrosine (NPY) immunoreactivity in norepinephrine-containing cells and nerves of the mammalian adrenal gland. Endocrinology 114, 14601462.
  • Verberne A. J. and Sartor D. M. (2010) Rostroventrolateral medullary neurons modulate glucose homeostasis in the rat. Am. J. Physiol. Endocrinol. Metab. 299, E802E807.
  • Vietor I., Rusnak M., Viskupic E., Blazicek P., Sabban E. L. and Kvetnansky R. (1996) Glucoprivation by insulin leads to trans-synaptic increase in rat adrenal tyrosine hydroxylase mRNA levels. Eur. J. Pharmacol. 313, 119127.
  • Whim M. D. (2006) Near simultaneous release of classical and peptide cotransmitters from chromaffin cells. J. Neurosci. 26, 66376642.
  • Zhang P., Zheng J., Vorce R. L. and Hexum T. D. (2000) Identification of an NPY-Y1 receptor subtype in bovine chromaffin cells. Regul. Pept. 87, 913.
  • Zheng J., Zhang P. and Hexum T. D. (1997) Neuropeptide Y inhibits chromaffin cell nicotinic receptor-stimulated tyrosine hydroxylase activity through a receptor-linked G protein-mediated process. Mol. Pharmacol. 52, 10271033.